Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-16-142071

Director disposed of 571,741 shares (other)

  • Director acquired 265,942 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Tullman Stephen A. Director 2016-09-15 Other disposition −521,739 0 I
Tullman Stephen A. Director 2016-09-15 Other acquisition +116,999 116,999 D
Tullman Stephen A. Director 2016-09-15 Other acquisition +144,153 144,153 I
Tullman Stephen A. Director 2016-09-15 Other disposition −50,002 94,151 I
Tullman Stephen A. Director 2016-09-15 Other acquisition +4,790 121,789 D
Loading xslF345X03/doc4.xml…